Selected article for: "complicated infection and mechanical ventilation"
Author: Shinoda, Masahiro; Kamachi, Kenichi; Ota, Shinichiro; Yoshimatsu, Lynn; Boku, Ryuichi; Yoshida, Yuto; Hirouchi, Takatomo; Shinada, Kanako; Sato, Takashi; Morikawa, Miwa; Iwata, Koki; Matsumoto, Takashi; Shinkai, Masaharu
Title: Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
  • Cord-id: mhw61kw5
  • Document date: 2021_1_1
    • ID: mhw61kw5
    Snippet: Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid.
    Document: Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy.

    Search related documents:
    Co phrase search for related documents
    • admission chest radiography and lung ground glass opacity: 1
    • admission time and lung edema: 1
    • admission time and lung ground glass opacity: 1
    • admission time and lung protective: 1, 2, 3
    • admission time and lung tissue: 1
    • admission time and macrolide antibiotic: 1, 2
    • admission time and macrolide therapy: 1
    • local inflammation and lung edema: 1
    • local inflammation and lung local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • local inflammation and lung protective: 1, 2, 3, 4
    • local inflammation and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lung edema and lymphocyte fraction: 1
    • lung tissue and macrolide antibiotic: 1